Previous Article | Next Article ![]()
Journal of Clinical Microbiology, February 1998, p. 453-457, Vol. 36, No. 2
MRC, SAIMR, WITS, Pneumococcal Diseases
Research Unit, Department of Medical Microbiology and School of
Pathology, South African Institute for Medical Research, Johannesburg,
2000, South Africa
Received 6 August 1997/Returned for modification 17 October
1997/Accepted 12 November 1997
A seminested-PCR assay, based on the amplification of the
pneumococcal penicillin-binding protein 2B gene (pbp2B),
was developed for the detection of penicillin-resistant and
-susceptible pneumococci in cerebrospinal fluid (CSF) specimens.
Species-specific primers (P5 and P6) which amplified a 682-bp conserved
region of the transpeptidase-encoding region of the pbp2B
gene were used. Four "resistance" primers were designed to bind to
altered areas of the pbp2B gene identified in
penicillin-resistant South African wild-type strains. Together with the
downstream primer P6, the upstream resistance primers amplified
fragments which were used to detect the presence of penicillin
resistance. This system identified all 35 of the S. pneumoniae isolates evaluated, including strains of 11 different serotypes and a range of penicillin-resistant and -susceptible strains.
The specificity of the assay was demonstrated by its inability to
amplify DNA from other bacterial species which commonly cause
meningitis. It was possible to detect pneumococcal DNA from culture-negative CSF inoculated with 2.5 pg of purified DNA or 18 CFU.
Analysis of 285 CSF specimens showed that PCR detected the pneumococcus
in 18 samples positive by culture, including the identification of four
penicillin-resistant isolates. The positive predictive value and the
negative predictive value of the assay were each 100%.
0095-1137/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Rapid Detection of Penicillin-Resistant Streptococcus
pneumoniae in Cerebrospinal Fluid by a Seminested-PCR
Strategy
*
Corresponding author. Mailing address: Pneumococcal
Diseases Research Unit, SAIMR, P.O. Box 1038, Johannesburg, 2000, South Africa. Phone: 27-11-4899335. Fax: 27-11-4899332. E-mail:
174mig{at}chiron.wits.ac.za.
This article has been cited by other articles:
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. |
|---|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|